Literature DB >> 12872291

Schizophrenia hippocampus has elevated expression of chondrex glycoprotein gene.

Carmen Chung1, Teresa Tallerico, Philip Seeman.   

Abstract

To identify genes associated with schizophrenia, DNA microarray chips were used to compare schizophrenia and control hippocampus tissues, revealing four genes with elevated expression, chondrex (or YKL-40), histamine-releasing factor, HERC2, and heat-shock 70. However, using the quantitative real-time polymerase chain reaction method, only the expression of the chondrex gene, an extracellular matrix glycoprotein involved in cell growth and migration, was found to be significantly elevated, by 1.8-fold. Real-time PCR found that the expression of the histamine-releasing factor gene, known to be associated with cognitive deficits in Alzheimer's disease, was significantly reduced by 19%. The expression of the HERC2 and heat-shock 70 genes, as measured by real-time PCR, were not significantly altered in the schizophrenia hippocampus. The altered gene expression of chondrex suggests that disruption in neuronal migration may be involved in schizophrenia. The change in expression of the histamine-releasing factor gene suggests that this gene may be associated with the negative symptoms of impaired learning and memory in schizophrenia. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12872291     DOI: 10.1002/syn.10228

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  19 in total

Review 1.  Potential microbial origins of schizophrenia and their treatments.

Authors:  S Hossein Fatemi
Journal:  Drugs Today (Barc)       Date:  2009-04       Impact factor: 2.245

Review 2.  Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models.

Authors:  Chi-Ying Lin; Akira Sawa; Hanna Jaaro-Peled
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

3.  Brain barriers and a subpopulation of astroglial progenitors of developing human forebrain are immunostained for the glycoprotein YKL-40.

Authors:  Camilla Bjørnbak; Christian B Brøchner; Lars A Larsen; Julia S Johansen; Kjeld Møllgård
Journal:  J Histochem Cytochem       Date:  2014-03-04       Impact factor: 2.479

Review 4.  Extracellular matrix abnormalities in schizophrenia.

Authors:  Sabina Berretta
Journal:  Neuropharmacology       Date:  2011-08-16       Impact factor: 5.250

Review 5.  Imaging phenotypes and genotypes in schizophrenia.

Authors:  Jessica A Turner; Padhraic Smyth; Fabio Macciardi; James H Fallon; James L Kennedy; Steven G Potkin
Journal:  Neuroinformatics       Date:  2006

6.  Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia.

Authors:  Xinzhi Zhao; Ruqi Tang; Bo Gao; Yongyong Shi; Jian Zhou; Shengzhen Guo; Jing Zhang; Yabing Wang; Wei Tang; Junwei Meng; Sheng Li; Hongsheng Wang; Gang Ma; Chuwen Lin; Yue Xiao; Guoyin Feng; Zhiguang Lin; Shaomin Zhu; Yangling Xing; Hong Sang; David St Clair; Lin He
Journal:  Am J Hum Genet       Date:  2006-11-13       Impact factor: 11.025

7.  In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases.

Authors:  Dafna Bonneh-Barkay; Guoji Wang; Adam Starkey; Ronald L Hamilton; Clayton A Wiley
Journal:  J Neuroinflammation       Date:  2010-06-11       Impact factor: 8.322

Review 8.  The neurodevelopmental hypothesis of schizophrenia, revisited.

Authors:  S Hossein Fatemi; Timothy D Folsom
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

9.  Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia.

Authors:  Dominique Arion; Travis Unger; David A Lewis; Pat Levitt; Károly Mirnics
Journal:  Biol Psychiatry       Date:  2007-06-13       Impact factor: 13.382

10.  Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia.

Authors:  Jing Qin Wu; Xi Wang; Natalie J Beveridge; Paul A Tooney; Rodney J Scott; Vaughan J Carr; Murray J Cairns
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.